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Abstract: Two-dimensional gel electrophoresis provides robust comparative analysis of 
skeletal muscle, but this technique is laborious and limited by its inability to resolve all 
proteins. In contrast, orthogonal separation by SDS-PAGE and reverse-phase liquid 
chromatography (RPLC) coupled to mass spectrometry (MS) affords deep mining of the 
muscle proteome, but differential analysis between samples is challenging due to the 
greater level of fractionation and the complexities of quantifying proteins based on the 
abundances of their tryptic peptides. Here we report simple, semi-automated and time 
efficient (i.e., 3 h per sample) proteome profiling of skeletal muscle by 1-dimensional 
RPLC electrospray ionisation tandem MS. Solei were analysed from rats (n = 5, in each 
group) bred as either high- or low-capacity runners (HCR and LCR, respectively) that 
exhibited a 6.4-fold difference (1,625 ± 112 m vs. 252 ± 43 m, p < 0.0001) in running 
capacity during a standardized treadmill test. Soluble muscle proteins were extracted, 
digested with trypsin and individual biological replicates (50 ng of tryptic peptides) 
subjected to LC-MS profiling. Proteins were identified by triplicate LC-MS/MS analysis of 
a pooled sample of each biological replicate. Differential expression profiling was 
performed on relative abundances (RA) of parent ions, which spanned three orders of 
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magnitude. In total, 207 proteins were analysed, which encompassed almost all enzymes of 
the major metabolic pathways in skeletal muscle. The most abundant protein detected was 
type I myosin heavy chain (RA = 5,843 ± 897) and the least abundant protein detected was 
heat shock 70 kDa protein (RA = 2 ± 0.5). Sixteen proteins were significantly (p < 0.05) 
more abundant in HCR muscle and hierarchal clustering of the profiling data highlighted 
two protein subgroups, which encompassed proteins associated with either the respiratory 
chain or fatty acid oxidation. Heart-type fatty acid binding protein (FABPH) was 1.54-fold 
(p = 0.0064) more abundant in HCR than LCR soleus. This discovery was verified using 
selective reaction monitoring (SRM) of the y5 ion (551.21 m/z) of the doubly-charged 
peptide SLGVGFATR (454.19 m/z) of residues 23–31 of FABPH. SRM was conducted on 
technical replicates of each biological sample and exhibited a coefficient of variation of 
20%. The abundance of FABPH measured by SRM was 2.84-fold greater (p = 0.0095) in 
HCR muscle. In addition, SRM of FABPH was performed in vastus lateralis samples of 
young and elderly humans with different habitual activity levels (collected during a 
previous study) finding FABPH abundance was 2.23-fold greater (p = 0.0396) in 
endurance-trained individuals regardless of differences in age. In summary, our findings in 
HCR/LCR rats provide protein-level confirmation for earlier transcriptome profiling work 
and show LC-MS is a viable means of profiling the abundance of almost all major 
metabolic enzymes of skeletal muscle in a highly parallel manner. Moreover, our approach 
is relatively more time efficient than techniques relying on orthogonal separations, and we 
demonstrate LC-MS profiling of the HCR/LCR selection model was able to highlight 
biomarkers that also exhibit differences in trained and untrained human muscle. 
Keywords: aerobic capacity; animal selection model; exercise training; heart-type fatty 
acid binding protein; FABPH; Fabp3; human vastus lateralis; selective reaction monitoring 
 
1. Introduction 
Proteome profiling has proved to be a pragmatic means of discovering novel information and 
identifying new avenues of research. In the field of skeletal muscle proteomics, differential expression 
analysis has been used to investigate human proteome responses to exercise [1], ageing [2], bed-rest [3] 
and obesity [4]. In addition, proteomic techniques have been applied to a wide variety of experimental 
models, including denervation [5] and electrical stimulation [6]. These works have used two-dimensional 
gel electrophoresis to resolve proteins, which are then identified from mass spectrometry of in-gel 
digests. This approach offers robust comparative analysis of protein species, which represent different 
post-translational states of a protein [7]. However, 2D electrophoresis requires a significant level of 
skill, is laborious and has a number of technical limitations, including difficulties in resolving proteins 
at the extremes of the mass and pH scales, and a limited dynamic range.  
Efforts have been made to perform differential analyses using high-performance liquid 
chromatography (LC) coupled online with mass spectrometry (MS). This approach promises largely 
automated analysis but currently it is necessary to conduct profiling on tryptic peptides rather than 
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intact proteins, which brings a substantive increment in sample complexity and severs the connection 
linking site-specific post-translational modifications with functional protein species. Nonetheless, 
useful information regarding changes in protein abundance can be collected, but the density of peptide 
profiling data places a formidable burden on separation and mass spectrometry technologies. In muscle 
proteomics, the time efficiency of orthogonal gel and liquid separations has been investigated [8]. The 
combination of SDS-PAGE with LC-ESI-MS/MS, known as GeLC-MS/MS [9] is of particular utility 
in skeletal muscle protein identification. However, spectral counting (e.g., [10]) or peptide labelling 
techniques (e.g., [1]) are necessary in order to perform differential profiling using GeLC-MS/MS. 
GeLC-MS/MS also requires substantial (~30 h) machine time for each biological replicate, due to the 
sequential analysis of individual fractions of each sample.  
Here we address the question of whether separation of soluble muscle proteins using simple  
one-dimensional liquid chromatography provides useful information regarding muscle phenotype. 
Skeletal muscle is ideal substrate for such label-free LC-MS profiling because the abundance of 
metabolic enzymes and myofibrillar proteins that underpin muscle function is high and spans a 
relatively narrow dynamic range. Phenotyping of muscle is typically based on the relative distribution 
of myosin heavy chain (MyHC) isoforms. However, such classification ignores the fact that myofibres 
can exhibit broadly different metabolic properties yet have identical MyHC content (see [11]). Indeed, 
while changes in the metabolic and contractile properties of skeletal muscle often co-occur (e.g., 
during ageing [2,12]), in most instances muscle metabolism is more labile than myofibrillar structure. 
In this regard, metabolic profiling is likely to be a more sensitive and discriminative means of 
describing muscle than myofibre phenotype.  
Traditionally, the capacity of metabolic pathways is inferred from the maximal activities of key 
rate-limiting enzymes, including citrate synthase (CS; tricarboxylic acid cycle), phosphofructokinase 
(PFK; glycolysis), 3-hydroxyacyl-CoA dehydrogenase (β-HAD; β-oxidation), or the concentrations of 
marker proteins such as cytochrome c (respiratory chain) [13]. However, such assays require relatively 
large amounts of raw material and must be performed independently. Proteomic techniques provide 
more comprehensive and parallel analysis, and this may aid the discovery of biomarkers of disease 
processes. For example, it is conceivable, that an enzyme not typically recognised as being rate-limiting 
under normal circumstances could nonetheless influence flux through the pathway under specific 
conditions. In addition, many well characterised metabolic enzymes are known to also contribute to 
cellular processes other than metabolism. For example, glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), which is typically the most abundant glycolytic enzyme in skeletal muscle, also plays a key 
role in nitrosylation of nuclear proteins [14]. Here we report LC-MS profiling of slow-twitch soleus 
muscle from two strains of rats, which have been artificially selected based on either high- or  
low-running capacity (HCR or LCR, respectively) [15]. Previously we reported proteomic analysis of 
hearts [16] from this model, but to date skeletal muscle has not been investigated using proteomic 
techniques. Based on previous literature (e.g., [17]) we did not expect soleus fibre type to be different 
between HCR and LCR but it is expected that HCR and LCR soleus will exhibit differences in 
metabolic profile, which makes it an ideal substrate for this work. 
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2. Experimental  
The inception of HCR-LCR strains from a founder population of genetically heterogeneous N:NIH 
rats has been described in detail [15]. Ten male HCR/LCR rats (n = 5, in each group) from generation 
25 (12–13 weeks old) were imported from the University of Michigan. The transfer of animals to the 
UK and subsequent procedures were conducted under the British Home Office Animals (Scientific 
Procedures) Act 1986 and according to UK Home Office Guidelines. Rats were housed in a 
conventional facility and the environmental conditions controlled at 20 ± 2 °C, 45%–50% relative 
humidity with a 12 h light (06:00–18:00 h) and dark cycle. Food and water were available ad libitum 
during a 14-day acclimatization period. After an overnight fast (~10 h), animals were asphyxiated with 
CO2 and killed by cervical dislocation. Skeletal muscles and other organs were isolated and cleaned of 
fat and connective tissue before being weighed and frozen in liquid nitrogen. 
Soleus muscles were pulverised in liquid nitrogen then homogenised on ice in 8 volumes of 1% 
Triton X-100, 50 mM Tris pH 7.4 containing Complete™ protease inhibitor (Roche Diagnostics, 
Lewes, UK). Samples were incubated on ice for 15 min then centrifuged at 1,000 rpm, 4 °C for 5 min. 
Supernates were precipitated in acetone and resuspended in Lysis Buffer: 7 M urea, 2 M thiourea, 4% 
(w/v) CHAPS, 30 mM Tris, containing Complete™ protease inhibitor (Roche Diagnostics, Lewes, 
UK). After clearing by centrifugation (12,000 g, 4 °C for 45 min) protein concentrations were 
measured using the Bradford assay (Sigma, Poole, Dorset, UK) and each sample adjusted to 5 μg μL−1. 
Aliquots containing 100 μg protein were precipitated in 5 volumes of acetone for 1 h at −20 °C. Pellets 
were resuspended in 0.1% (w/v) Rapigest SF (Waters; Milford, MA, USA) in 50 mM ammonium 
bicarbonate and incubated at 80 °C for 15 min. DTT was added (final concentration 1 mM) and 
incubated at 60 °C for 15 min followed by incubation whilst protected from light in the presence of  
5 mM iodoacetamide at 4 °C. Sequencing grade trypsin (Promega; Madison, WI, USA) was added at a 
protein ratio of 1:50 and digestion allowed to proceed at 37 °C overnight. Digestion was terminated  
by the addition of 2 μL concentrated TFA and peptide solutions were cleared by centrifugation at  
13,000 g for 5 min.  
Label-free liquid chromatography-mass spectrometry (LC-MS) analysis was performed using a 
quadrupole-high capacity ion-trap (HCT Ultra ETD II; Bruker Daltonics, Bremen, Germany) coupled 
online via an electrospray ionisation source to a nano-flow HPLC system (Ultimate 3000; Dionex, 
Sunnyvale, CA, USA). Tryptic digests (0.8 μg/μL) were diluted 1:10 with aqueous 0.1% formic acid 
(FA) and 5 μL loaded via a Zorbax 300SB C18 5 μm, 5 × 300 μm pre-column (Agilent Technologies 
Ltd.). Peptides were separated using a Zorbax 300SB C18 3.5 μm, 15 cm × 75 μm analytical reverse 
phase column (Agilent Technologies Ltd.) at a flow rate of 300 nL min
−1
 using a non-linear gradient 
rising to 40% acetonitrile 0.1% FA over 160 min. Mass spectra for LC-MS profiling were recorded 
between 200 m/z and 2,500 m/z using Standard Enhanced mode [8,100 (m/z)/s]. In addition, equivalent 
data-dependent tandem mass spectrometry (MS/MS) spectra were collected from triplicate analysis of 
a pooled standard comprising each HCR and LCR sample. MS/MS spectra of collision-induced 
dissociation fragment ions were recorded for the 5 most abundant precursors from each survey scan 
(350 m/z to 1,600 m/z). 
Both MS and MS/MS spectra were aligned using Progenesis LC-MS software (Nonlinear 
Dynamics, Newcastle, UK). Prominent ion features (mean ± SD per chromatogram: 455 ± 42) were 
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used as vectors to warp each dataset to a common reference chromatogram. An analysis window of  
15 min – 145 min and 200 m/z – 1,800 m/z was selected, which encompassed a total of 32,824 features 
with charge states of +2, +3 or +4. Log transformed MS data were normalised by inter-sample 
abundance ratio and used to investigate differences in expression between LCR and HCR groups by 
one-way analysis of variance. MS/MS spectra (16, 872 queries) were exported in Mascot generic 
format and searched against the Swiss-Prot database (2011.6) restricted to „Rattus‟ (7617 sequences) 
using a locally implemented Mascot server (version 2.2.03). The enzyme specificity was trypsin 
allowing 1 missed cleavage, carbamidomethyl modification of cysteine (fixed), deamidation of 
asparagine and glutamine (variable), oxidation of methionine (variable) and an m/z error of ± 0.5 Da. 
The Mascot output (xml format), restricted to non-homologous protein identifications was recombined 
with MS profile data in Progenesis LC-MS. Peptide features with MOWSE scores <10 (MudPIT 
scoring) were excluded and potential conflicts in peptide assignments were resolved manually. 
Functional annotation was conducted using the Database for Annotation, Visualization and Integrated 
Discovery (DAVID; [18]). Over-representation of gene ontology (GO) classes: cellular component 
(CC), biological process (BP) and molecular function (MF) was investigated. Association of proteins 
with pathways of the Kyoto Encyclopedia of Genes and Genomes (KEGG; [19]) was also assessed. 
Selective reaction monitoring (SRM) was used to verify the difference in heart-type fatty acid 
binding protein (FABPH) abundance detected by LC-MS profiling. FABPH exhibited the greatest fold 
difference between HCR and LCR muscles, and SRM of serum FABPH levels has previously been 
reported [20]. SRM was performed using similar instrument settings described for LC-MS profiling 
but samples were separated using a linear chromatographic gradient rising to 40% acetonitrile 0.1% 
FA in 15 min, rather than 160 min used during the initial profiling experiment. Samples were analysed 
in duplicate and in a randomised order. A single transition 454–551 was monitored, which represents 
the y5 ion (551.21 m/z) of the doubly charged peptide SLGVGFATR (2 + 454.19 m/z) of residues  
23–31 of FABPH. This peptide is identical in rat and human so we also performed the SRM assay on 
human muscle collected during a separate experiment, reported in [21]. Biopsy samples of vastus 
lateralis of young or elderly individuals that had either high or low levels of habitual physical activity, 
were processed and analysed equivalently to the HCR/LCR soleus muscle. Statistical analysis was 
conducted by 2-way analysis of variance (age versus activity level).  
3. Results 
3.1. Physical and Physiological Characteristics of HCR and LCR Rats 
The body weight of LCR (460 ± 40 g) was 1.38-fold greater (p < 0.0001) than HCR (334 ± 36 g) 
and there was a 6.44-fold difference (p < 0.0001) difference in running capacity (1,625 ± 112 m vs.  
252 ± 43 m) between HCR and LCR strains (Figure 1). 
  
Proteomes 2013, 1 295 
 
 
Figure 1. Physical characteristics of high-(HCR) and low-capacity runner (LCR) rats. 
Furthest distance (m) completed during a standardised treadmill test of LCR and HCR rats 
at approximately 10 weeks of age (A). Body weight of LCR and HCR rats prior to tissue 
harvesting at approximately 14 weeks of age (B). Data are expressed as Mean ± SD (n = 5, 
in each group), * p < 0.05.  
 
3.2. LC-MS Profiling of Soluble Muscle Proteins 
In total 207 protein entries (2,999 peptides) mapped to features in progenesis LC-MS and were used 
for quantitative analysis. Figure 2 illustrates the data analysis process and a spreadsheet (Table S1) 
detailing the entire list of Mascot protein identifications and normalised protein abundance data is 
available. Based on normalised ion intensities the most abundant proteins included type I myosin 
heavy chain (MYH7), carbonic anhydrase, skeletal muscle alpha actin and creatine kinase. The least 
abundant proteins detected were heat shock protein 70 kDa protein 4, enoyl-CoA delta isomerase 2, and 
nuclear pore membrane protein 210. Normalised relative abundances (RA) of proteins analysed in the 
current work spanned 3 orders of magnitude from 2 (heat shock 70 kDa protein, HSP74) to 5,843 ± 897 
(type I myosin heavy chain, MYH7). As expected, the relative abundance of enzymes that contribute 
to the first phase of glycolysis (e.g., phosphoglucomutase 1, RA = 95 ± 9) was approximately half  
that of enzymes involved in the second phase (e.g., phosphoglycerate mutase 2, RA = 174 ± 23). 
Consistent with the slow-twitch phenotype of the soleus, the ratio of lactate dehydrogenase A  
(RA = 122 ± 12) to lactate dehydrogenase B (RA = 234 ± 65) was approximately 1:2, and the ratio of 
fast troponin I (RA = 9 ± 2) to slow troponin I (RA = 77 ± 15) was approximately 1:9. Although the 
soleus typically contains approximately 20% type IIa fibres, proteotypic peptides of myosin-2 (MYH2) 
were not detected, therefore, the ratio of type I and IIa fibres cannot be reported. 
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Figure 2. Label-free LC-MS profiling. LC-MS spectrum (A) showing the separation of 
tryptic peptides by reversed-phase liquid chromatography retention time (min) and  
mass-to-charge ratio (m/z). Inset highlights the area of selection of an extracted ion 
chromatogram (B) of peptide 698.86 m/z. Demarcation of the isotope envelope of peptide 
698.86 m/z (C) and 3-dimensional representation of the peptide in representative LCR and 
HCR samples (D). 
 
Functional annotation of the non-redundant protein list revealed the top-ranked biological process 
was generation of precursor metabolites and energy (53 proteins) and the most abundant cellular 
component was mitochondrion (95 proteins). The main molecular functions were: nucleotide binding 
(66 proteins), and metal ion binding (60 proteins). With the exception of 4 proteins (carnitine  
O-palmitoyl transferase II, hexokinase, pyruvate dehydrogenase E2 component and succinyl-CoA 
synthetase) each enzyme of the major pathways of fatty acid oxidation, glycolysis and the tricarboxylic 
acid cycle was quantified (i.e., 2 or more unique peptides) in the current LC-MS profiling experiment 
(Figure 3).  
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Figure 3. LC-MS profiling of muscle metabolic enzymes. The metabolic pathways of 
glycolysis, fatty acid β-oxidation and the tricarboxylic acid cycle are redrawn from the 
Kyoto Encyclopedia of genes and genomes (KEGG). For clarity the respiratory chain is not 
shown in its entirety, instead only subunits detected by LC-MS profiling are highlighted. 
Orange boxes display the common name of each enzyme, the adjacent box details the 
UniProt Rattus ID identified by LC-MS and the number of peptides attached to this 
sequence. Numbers in parentheses represent the number of detected peptides that were 
unique to that protein and subsequently used for differential expression profiling. A „heat 
map‟ coloring system is used to display proteins that were significantly more abundant in 
HCR (green) or LCR (red) groups. 
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Differential analysis of HCR and LCR samples highlighted 16 proteins (Table 1) that were more 
abundant (p < 0.05) in HCR soleus. No proteins were found to be significantly more abundant in LCR 
muscle. Proteins more abundant in HCR muscle were associated with aerobic metabolism and 
hierarchal clustering highlighted two prominent groups of proteins (respiratory chain and fatty acid 
metabolism) that shared patterns of expression across the biological replicates (Figure 4). 
Table 1. Differences in protein abundance between LCR and HCR soleus muscle. 
Description and Database ID relate to the protein name and accession number identified 
from Mascot searches of the UniProt Rattus database. Protein abundance relative 
differences (fold difference) in HCR compared to LCR are reported for proteins exhibiting 
significant (p < 0.05) differences in abundance at a FDR of <10%. 
Description Database ID 
MOWSE 
(peptides) 
Relative 
Abundance 
LCR 
Relative 
Abundance 
HCR 
Fold 
Diff. 
p value 
Respiratory chain       
Complex III       
Cytochrome b-c1 complex subunit 1 QCR1 322 (11) 109.87 ± 8.8 121.26 ± 5 1.10 0.0274 
Cytochrome b-c1 complex subunit 2 QCR2 459 (15) 166.77 ± 10.6 182.25 ± 8.7 1.09 0.0290 
Complex IV       
Cytochrome c oxidase subunit 2 COX2 111 (4) 50.93 ± 4.2 58.16 ± 5.9 1.14 0.0458 
Cytochrome c oxidase subunit 4 isoform 1 COX41 159 (5) 68.78 ± 5 79.39 ± 7.3 1.15 0.0206 
Complex V       
ATP synthase subunit beta ATPB 1185 (21) 740.15 ± 66.1 843.71 ± 69.4 1.14 0.0326 
ATP synthase subunit d ATP5H 64 (2) 40.96 ± 2.8 47.47 ± 3.4 1.16 0.0081 
ADP/ATP translocase 1 ADT1 562 (10) 457.55 ± 45.4 528.89 ± 40.5 1.16 0.0232 
Voltage-dependent anion-selective channel 
protein 1 
VDAC1 412 (12) 197.73 ± 13.1 221.68 ± 11.3 1.12 0.0111 
Voltage-dependent anion selective channel 
protein 3 
VDAC3 53 (4) 45.82 ± 3.7 52.94 ± 3.9 1.16 0.0137 
Electron transfer flavoprotein subunit beta ETFB 279 (8) 113.23 ± 8.6 128.03 ± 10.4 1.13 1.13 
Fatty acid transport       
Fatty acid-binding protein, heart FABPH 349 (7) 328.72 ± 62.3 504.97 ± 116.5 1.54 0.0064 
Fatty acid-binding protein, adipocyte FABP4 95 (4) 48.06 ± 5.2 55.47 ± 5.7 1.15 0.0426 
Methylmalonate-semialdehyde dehydrogenase MMSA 115 (5) 55.59 ± 2 58.63 ± 5 1.05 0.0235 
Dihydrolipoyl dehydrogenase DLDH 184 (6) 57.83 ± 3.8 66.78 ± 4.9 1.15 0.0077 
3-Ketoacyl-CoA thiolase THIM 396 (7) 89.21 ± 10.6 111.88 ± 11.4 1.25 0.0071 
Enoyl-CoA hydratase ECHM 76 (3) 21.76 ± 2.2 25.97 ± 3.1 1.19 0.0245 
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Figure 4. Hierarchal clustering of differentially expressed proteins. Hierarchal clustering 
highlighted 2 prominent groupings within LC-MS profiling data. Eleven proteins 
associated with the respiratory chain, that were differentially expressed in HCR and LCR 
soleus (see Table 1) shared patterns of variation between individual animals. Similarly,  
3 of the differentially expressed proteins associated with fatty acid metabolism were also 
clustered based on their shared variability.  
 
3.3. SRM Verification of FABPH 
LC-MS profiling found FABPH exhibited the greatest difference (1.54-fold, p = 0.0064) in 
abundance between HCR and LCR muscle. SRM verified this finding and measured a 2.84-fold 
greater (p = 0.0095) abundance in HCR soleus (Figure 5a). The reproducibility of the SRM method 
was assessed using technical replicates of HCR and LCR samples. The assay exhibited no significant 
systematic bias in retention time or area under the curve of the ion chromatogram, which was used to 
estimate abundance. The average retention time was 21 ± 0.2 min (coefficient of variation 0.4%) and 
the coefficient of variation of measures of FABPH abundance was 20%. SRM of FABPH in human 
muscle found training status significantly (p = 0.0396) effected FABPH abundance. Endurance-trained 
humans had 2.23-fold greater levels of FABPH compared to untrained individuals (Figure 5b), 
whereas FABPH content was not significantly affected by age. 
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Figure 5. Selective reaction monitoring of FABPH. Annotated MS/MS spectra of the 
doubly-charged precursor, 454.19 m/z (A) of residues 23–31 (SLGVGFATR) of FABPH 
and (B) monitoring of the selected fragment ion (551.21 m/z). Selective reaction 
monitoring chromatograms of the 454.19 m/z to 551.21 m/z transition in HCR and LCR 
soleus (C) and human vastus lateralis (D). In C, the red shaded area represents a HCR 
sample and the blue area represents a LCR sample. In D, data from a young trained 
individual (red) is overlaid by data from elderly trained (pink), elderly untrained (green) 
and young sedentary (blue) individuals. The histograms represent the ion abundance of the 
areas under the chromatogram curves for the respective groups. Data are presented as 
means ± SD (n = 5, in each group), * p < 0.05. 
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4. Discussion 
The current work reports a time- and sample-efficient method of profiling the expression of the 
major metabolic enzymes in skeletal muscle. Using a simple LC-MS approach we surveyed more than 
200 proteins, including almost all enzymes of the major metabolic pathways (i.e., glycolysis, fatty acid 
β-oxidation, the tricarboxylic acid cycle and some components of the respiratory chain; Figure 3). 
Recently [10], spectral counting was successfully combined with GeLC-MS/MS to perform 
differential analysis of 438 proteins in human skeletal muscle. However, that relatively broad coverage 
of the muscle proteome was achieved at the expense of substantially greater machine time and sample 
usage. Hussey et al. [10] separated 60 μg aliquots of muscle homogenate in to 20 molecular weight 
fractions, which were analysed by LC-MS/MS over 90 min periods. This equates to roughly 1,800 min 
machine time per sample (biological replicate). In the current work, approximately 50 ng of tryptic 
peptides from each biological replicate was resolved by LC-MS of 180 min duration. This represents a 
10-fold improvement in time efficiency and a greater than 100-fold increase in sample efficiency; 
albeit at the expense of a 2-fold decrease in the number of proteins detected. We believe the current 
approach represents a useful compromise that may lead to more widespread application of LC-MS 
profiling as a semi-automated and efficient means of phenotyping skeletal muscle. 
Here, we applied LC-MS profiling to muscle of HCR and LCR rats that exhibit differences in 
exercise capacity, cardiometabolic disease risk and life expectancy [22]. Deterioration in the metabolic 
flexibility of skeletal muscle is associated with insulin resistance, which is a cardinal feature of human 
metabolic syndrome, and also accompanies natural ageing. Metabolic dysfunction and insensitivity to 
insulin are also evident as correlated traits of selection on low running capacity. For example, in the 
basal (fasted) state LCR muscle has lesser uptake and oxidation of fatty acids and, when stimulated by 
insulin, glucose uptake of LCR hindlimb muscles is significantly less than HCR [23]. Transcriptome 
profiling [17] reports enrichment of gene-sets, including oxidative phosphorylation, fatty acid 
metabolism and PPAR signalling, correlate with the differences in running activity of LCR and HCR 
animals. However, such differences between HCR and LCR are generally more pronounced in 
predominantly fast- compared to slow-twitch muscles. The proportion of type IIa MyHC (42 ± 16% 
versus 22 ± 14%) was significantly greater in HCR gastrocnemius used for transcriptome analysis, 
which may have contributed to some of the differences observed in metabolic markers. To obviate 
effects due to myofibre profile, we performed proteomic analysis of slow-twitch soleus muscle that has 
consistent myofibre proportions (~80% type I, ~20% type IIa) in HCR and LCR rats [17].  
LC-MS profiling detected 16 significant differences between HCR and LCR soleus muscles. 
Consistent with the selection paradigm and earlier reported [17] differences in soleus mitochondrial 
content, the majority of proteins were more abundant in HCR muscle (Table 1) and were associated 
with the mitochondrial respiratory chain. Hierarchal clustering of the LC-MS profiling data highlighted 
2 principal groups of differentially expressed proteins (Figure 4), which either encompassed 
components of the respiratory chain or were associated with fatty acid metabolism. This outcome 
supports the earlier [17] gene-set enrichment analysis of HCR/LCR gastrocnemius transcriptomes and 
provides protein-level confirmation for some of the transcript data. Specifically, HCR soleus had 
greater abundance of cytochrome b-c1 complex subunit 1 and cytochrome c oxidase subunit 4, isoform 1, 
which were included in the oxidative phosphorylation gene-set enriched in HCR gastrocnemius 
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muscle. In addition, 3-ketoacyl-CoA thiolase (THIM) and enoyl-CoA hydratase (ECHM) included in 
the HCR gastrocnemius gene-set “Fatty acid oxidation” were also more abundant in HCR soleus 
(Table 1). In the current work, THIM and ECHM abundances correlated closely with FABPH (Figure 4), 
which was listed separately under “PPAR signalling” by gene-set enrichment analysis. Thus two separate 
and unbiased profiling approaches have come to highly consistent conclusions regarding prominent 
networks (and biomarkers thereof) underpinning innate differences in muscle aerobic capacity. 
On average, the aerobic capacity of HCR hindlimb muscles is ~80% greater than LCR and this 
difference is underpinned by both a larger yield and greater efficiency of mitochondria isolated from 
HCR animals [24]. Cytochrome c oxidase subunit 1 is commonly used as a mitochondrial biomarker 
because it is encoded from the mitochondrial genome and is the main catalytic subunit of the terminal 
complex (Complex IV) of the electron transport chain. Consistent with earlier findings (e.g., [25,26]) 
the abundance of COX1 is significantly greater in mitochondria isolated from HCR hindlimb muscle [24]. 
However, differences in the abundance of protein biomarkers of other complexes of the electron 
transport chain were not detected [24], which led the authors to conclude the greater aerobic capacity 
of HCR is in part due to differences in flux control of the respiratory chain. COX1 was not detected by 
LC-MS profiling but we report significant differences in the abundance of several other proteins 
associated with the respiratory chain, including subunit 1 of Complex III and adenine nucleotide 
transferase (ANT), which were not significantly different when investigated by western blotting of 
mitochondria isolated from the entire hindlimb [24]. In addition, we report greater abundance in HCR 
soleus of mitochondrial encoded COX subunit 2 and nuclear encoded COX subunit 4, as well as 2 
subunits of F1-ATP synthase. These data support earlier findings [26] reporting significantly greater 
COXI in HCR soleus, along with greater abundance of cytochrome b-c1 complex subunit 2, peroxisome 
proliferator-activated receptor gamma (PPARγ), PPARγ co-activator 1 alpha, and F1-ATPase. An 
elevated abundance of muscle ATP synthase subunits is commonly reported in response to exercise 
training [27] and our current data add to evidence that ATP synthase may represent a candidate 
biomarker of muscle aerobic capacity. Interestingly, rate-limiting enzymes such as citrate synthase, 
which are traditionally used to assay muscle metabolism were not differentially expressed between 
HCR and LCR.  
A decline in maximal aerobic capacity occurs with advancing age and, consistent with data from 
humans, the life expectancy of HCR and LCR rats can be predicted by their maximum oxygen uptake 
(VO2max) during adulthood [22]. Maximum lifespan is similar in HCR and LCR populations but the 
median age of death is ~24 months for LCR and 30 months for HCR, which equates to a 28% 
difference in life expectancy [22]. While LCR exhibit comparatively greater deterioration of cardiac 
function during ageing, impairments in muscle aerobic metabolism may also contribute to the 
relatively poor life expectancy of animals selected for low running capacity. The interaction between 
ageing and aerobic capacity is complex and likely each is underpinned by multigenic mechanisms. For 
example, Bell et al. [28] reports a protein interaction network of 2,338 nodes constructed from 175 
human homologs of genes that modify lifespan when mutated in model organisms such as yeast and 
Caenorhabditis elegans. This „longevity interactome‟ was then restricted to genes that also exhibit 
significant differences in expression between muscle of young and elderly individuals to highlight a 
core subnetwork of 325 age-associated proteins [28]. Amongst those core proteins tightly associated 
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with ageing were COX41, FABPH and ATP5H, which were found to be differentially expressed 
between HCR and LCR soleus muscle (Table 1).  
FABPH exhibited the most prominent difference between HCR and LCR muscles, and we used 
selective reaction monitoring (SRM) to verify this initial discovery. SRM assays afford greater 
selectivity and sensitivity than LC-MS profiling and can often be performed more rapidly. During  
LC-MS profiling relative quantification is achieved by monitoring the intensity of parent-ion masses 
but this may be susceptible to interference from unrelated peptides of similar mass-to-charge ratio. In 
contrast, SRM analysis monitors the intensity of a known product-ion mass during fragmentation of a 
selected parent ion (known as a transition) and this additional level of filtering affords greater 
selectivity and sensitivity. SRM analysis of FABPH in rat serum has previously been reported [20] and 
we report an identical parent/fragment ion transition can be used in rat skeletal muscle with good 
reliability (i.e., 20% coefficient of variation). Our method development was also aided by use of the 
same MS platform for both LC-MS profiling and SRM [29], and we were able to shorten analysis time 
per sample by a factor of 10. SRM confirmed our discovery by LC-MS profiling that FABPH is 
significantly more abundant in HCR muscle (Figure 5C). FABPH binds long-chain fatty acids in the 
sarcoplasm and the abundance of this protein is tightly associated with the capacity of muscle to take 
up fatty acids [30]. Thus the lesser FABPH content of LCR muscle is likely to be a key factor 
contributing to the lesser uptake of FA in LCR muscle (e.g., [23]) under basal conditions. In addition 
FABPH is also known to have reciprocal effects on the utilisation of glucose and long-chain fatty acids 
during exercise [31]. Therefore the lesser abundance of FABPH in LCR muscle may also play a role in 
the relative poor running capacity of these animals. Paradoxically, FABPH is less abundant in muscle 
of normal-weight individuals compared to obese and morbidly obese patients [4], which may be 
expected to have relatively poorer exercise capacity. This phenomenon is likely to be connected with 
the elevated storage of intramuscular triacylglycerides, which occurs in both obese individuals and 
endurance-trained athletes [32]. The link between FABPH and the longevity interactome [28] is 
consistent with proteomic analysis in rats. Proteomic analysis of FABPH in muscle of young and 
elderly rats [33] reports significantly greater abundance of FABPH in elderly gastrocnemius but this 
could be due to the loss of fast-twitch fibres and relatively greater proportion of slow-twitch fibres in 
gastrocnemius of old rats [34]. In contrast, we found no significant difference in FABPH abundance 
between normal-weight young and elderly people (Figure 5D). Whereas, endurance-trained individuals 
had a 2.23-fold greater abundance of FABPH, which suggests age-associated declines in physical 
activity or training status (i.e., muscle aerobic capacity) may have greater influence on FABPH 
abundance than age per se. 
5. Conclusions 
In summary, we report time efficient and automated differential analysis of the top 200 abundant 
proteins in skeletal muscle. Further strengths of this work include sample efficiency and the breadth 
and parallel nature of the analysis, which eliminates variability introduced by performing numerous 
enzyme activity assays in series. Using a model of artificial selection we highlight prominent 
biomarkers of aerobic capacity and show LC-MS profiling represents a viable and efficient method of 
phenotyping muscle based on the relative abundance of metabolic enzymes. Moreover, these data can 
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be efficiently verified using SRM. Wider application of such techniques may lead to deeper 
understanding of muscle physiology and patho-physiology. In the future, use of higher resolution 
instrumentation may enable yet more comprehensive and rapid surveying of abundant muscle proteins 
and perhaps include signalling proteins that regulate these pathways. 
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